WHO Approves New Dengue Vaccine

WHO Approves New Dengue Vaccine

The World Health Organization (WHO) has approved a new vaccine for dengue. It is called TAK-003 and it was developed by a Japanese medicine-making company named Takeda Pharmaceuticals. This is the second dengue vaccine to receive verification from WHO. 

Dengue is a serious disease spread by mosquitoes. It affects between 100 and 400 million people each year. Most cases are in Asia, Africa, and the Americas. This approval will help the vaccine be used all around the world, especially in poorer countries. 

Vaccines help your body learn how to fight off germs so you don’t get sick. This vaccine is also the same. It will help the body learn how to fight dengue. The vaccine is recommended for children aged 6 to 16 in areas with high rates of dengue.

As the TAK-003 vaccine has been approved by WHO, now major global health groups can buy it. Countries such as the UK, Brazil, Argentina, Indonesia, and Thailand have also approved the use of this vaccine.